Salt-sensitive men show reduced heart rate variability, lower norepinephrine and enhanced cortisol during mental stress

Journal of Human Hypertension

Volumn 22, Issue 6, 2008, Pages 423-431

  Weber, C S ^a   Thayer, J F ^b,c   Rudat, M ^a   Sharma, A M ^d   Perschel, F H ^a   Buchholz, K ^e   Deter, H C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALPHA ADRENERGIC RECEPTOR; HYDROCORTISONE; NORADRENALIN;

ADULT; ARTICLE; BODY MASS; CAUCASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; GENETIC POLYMORPHISM; HEART RATE; HEART RATE VARIABILITY; HIGH SODIUM INTAKE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; HYPOTHESIS; MALE; MEAN ARTERIAL PRESSURE; MENTAL STRESS; NORADRENALIN BLOOD LEVEL; PATHOGENESIS; PHENOTYPE; SALT TOLERANCE; SODIUM RESTRICTION; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ADULT; BLOOD PRESSURE; HEART RATE; HUMANS; HYDROCORTISONE; HYPERTENSION; MALE; NOREPINEPHRINE; SODIUM CHLORIDE, DIETARY; STRESS, PSYCHOLOGICAL;

EID: 44049093521     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.11     Document Type: Article

References (60)

1. Weinberger MH. Pathogenesis of salt sensitivity of blood pressure. Curr Hypertens Rep 2006; 8(2): 166-170.
2. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 2001; 37: 429-432.
3. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S et al Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 1997; 13: 1734-1737.
4. Capasso G, Cantone A, Evangelista C, Zacchia M, Trepiccione F, Acone D et al. Channels, carriers, and pumps in the pathogenesis of sodium-sensitive hypertension. Semin Nephrol 2005; 25: 419-424.
5. Sharma AM, Cetto C, Schorr U, Spies KP, Distler A. Renal acid-base excretion in normotensive salt-sensitive humans. Hypertension 1993; 6: 884-990.
6. Sharma AM, Schorr U, Distler A. Insulin resistance in young salt-sensitive normotensive subjects. Hypertension 1993; 3: 273-279.
7. The GenSalt Collaborative Research Group. GenSalt: Rationale, design, methods and baseline characteristics of study participants. J Hum Hypertens 2007; 8: 639-646.
8. Alikhani-Koupaei R, Fouladkou F, Fustier P, Cenni B, Sharma AM, Deter HC et al. Identification of polymorphisms in the human 11beta-hydroxysteroid dehydrogenase type 2 gene promoter: Functional characterization and relevance for salt sensitivity. FASEB J 2007; 21(13): 3618-3628.
9. Mariniello B, Ronconi V, Sardu C, Pagliericcio A, Galletti F, Strazzullo P et al. Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension. Am J Hypertens 2005; 18: 1091-1098.
10. Lovati E, Ferrari P, Dick B, Jostarndt K, Frey BM, Frey FJ et al. Molecular basis of human salt sensitivity: The role of the 11beta-hydroxysteroid dehydrogenase type 2. J Clin Endocrinol Metab 1999; 84(10): 3745-3749.
11. Agarwal AK, Giacchetti G, Lavery G, Nikkila H, Palermo M, Ricketts M et al. CA-repeat polymorphism in intron 1 of HSD11B2: Effects on gene expression and salt sensitivity. Hypertension 2000; 36(2): 187-194.
12. Ferrari P, Lovati E, Frey FJ. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. J Hypertens 2000; 18(3): 241-248.
13. Brand E, Kato N, Chatelain N, Krozowski ZS, Jeunemaitre X, Corvol P et al. Structural analysis and evaluation of the 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) gene in human essential hypertension. J Hypertens 1998; 16(11): 1627-1633.
14. Watson Jr B, Bergman SM, Myracle A, Callen DF, Acton RT, Warnock DG. Genotic association of 11 beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacks. Hypertension 1990; 28(3): 478-482.
15. Williams TA, Mulatero P, Filigheddu F, Troffa C, Milan A, Argiolas G et al. Role of HSD11B2 polymorphisms in essential hypertension and the diuretic response to thiazides. Kidney Int 2005; 67(2): 631-637.
16. Miyoshi A, Suzuki H, Fujiwara M, Masai M, Iwasaki T. Impairment of endothelial function in salt-sensitive hypertension in humans. Am J Hypertens 1997; 10: 1083-1090.
17. Simon G. Experimental evidence for blood pressure-independent vascular effects of high sodium diet. Am J Hypertens 2003; 16: 1074-1078.
18. Skrabal F, Herholz H, Neumayr M, Hamberger L, Ledochowski M, Sporer H et al. Salt sensitivity in humans is linked to enhanced sympathetic responsiveness and to enhanced proximal tubular reabsorption. Hypertension 1984; 6: 152-158.
19. Mu J, Liu Z, Yang J. Blood pressure responses to cold pressor stress and its relation to sodium metabolism in salt-sensitive children. Clin Med J 1997; 77(8): 583-585.
20. Deter HC, Buchholz K, Schorr U, Schachinger H, Turan S, Sharma AM. Psychophysiological reactivity of salt-sensitive normotensive subjects. J Hypertens 1997; 15: 839-844.
21. Buchholz K, Schachinger H, Wagner M, Sharma AM, Deter HC. Reduced vagal activity in salt-sensitive subjects during mental challenge. Am J Hypertens 2003; 16: 531-536.
22. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science 1981; 213: 220-222.
23. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability. Standards of measurement, physiological interpretation, and clinical usè. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996; 17: 354-381.
24. Liao D, Cai J, Barnes RW, Tyroler HA, Rautaharju P, Holme I et al. Association of cardiac autonomic function and the development of hypertension: The ARIC study. Am J Hypertens 1996; 9: 1147-1156.
25. Schachinger H, Weinbacher M, Kiss A, Ritz R, Langewitz W. Cardiovascular indices of peripheral and central sympathetic activation. Psychosom Med 2001; 63: 788-796.
26. Piccirillo G, Fimognari FL, Munizzi MR, Bucca C, Cacciafesta M, Marigliano V. Age-dependent influence on heart rate variability in salt-sensitive hypertensive subjects. J Am Geriatr Soc 1996; 44 530-538.
27. Yo Y, Nagano M, Moriguchi A, Nakamura F, Kobayashi R, Okuda N et al Predominance of nocturnal sympathetic nervous activity in salt-sensitive normotensive subjects. Am J Hypertens 1996; 9 726-731.
28. Minami J, Kawano Y, Ishimitsu T, Takishita S. Blunted parasympathetic modulation in salt-sensitive patients with essential hypertension: evaluation by power-spectral analysis of heart-rate variabilily. J Hypertens 1997; 15(7): 727-735.
29. Campese VM, Romoff MS, Levitan D, Saglikes Y, Friedler RM, Massry SG. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int 1982; 21(2): 371-378.
30. Gill Jr JR, Gullner G, Lake CR, Lakatua DJ, Lan G. Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension 1988; 11(4): 312-319.
31. Kawano Y, Yoshida K, Kawamura M, Yoshimi H, Ashida T, Abe H et al. Sodium and noradrenaline in cerebrospinal fluid and blood in salt-sensitive and non-salt-sensitive essential hypertension. Clin Exp Pharmacol Physiol 1992; 19(4): 235-241.
32. Kerstens MN, van der Kleij FG, Boonstra AH, Sluiter WJ, Koerts J, Navis G et al. Salt loading affects cortisol metabolism in normotensive subjects: Relationships with salt sensitivity. J Clin Endocrinol Metab 2003; 88: 4180-4185.
33. Lewicka S, Nowicki M, Vecsei P. Effect of sodium restriction on urinary excretion of cortisol and its metabolites in humans. Steroids 1998; 63: 401-405.
34. Litchfield WR, Hunt SC, Jeunemaitre X, Fisher ND, Hopkins PN, Williams RR et al. Increased urinary free cortisol: A potential intermediate phenotype of essential hypertension. Hypertension 1998; 31: 569-574.
35. Steptoe A, Marmot M. Impaired cardiovascular recovery following stress predicts 3-year increases in blood pressure. J Hypertens 2005; 23: 529-536.
36. Deter HC, Buchholz K., Schorr U, Mathiak K, Sharma AM. Salt-sensitivity and other predictors of stress-related cardiovascular reactivity in healthy young males. Clin Exp Hypertens 2001; 23: 213-225.
37. Johannes B, Eichhorn C, Fischer F. A complex experimental assessment for objective description of hierarchical psychophysiological behavior as human regulatory phenotype. J Grávit Physiol 1994; 1: 73-74.
38. Vasey MW, Thayer JF. The continuing problem of false positives in repeated measures ANOVA in psychophysiology: A multivariate solution. Psychophysiololgy 1987; 24: 479-486.
39. Julius S, Nesbitt S. Sympathetic overactivity in hypertension. A moving target. Am J Hypertens 1996; 9: 113S-120S.
40. Brook RD, Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens 2000; 13: 112S-122S.
41. Noll G, Wenzel RR, Schneider M, Oesch V, Binggeli C, Shaw S et al. Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation 1996; 93(5): 866-869.
42. Overlack A, Ruppert M, Kolloch R, Gobel B, Kraft K, Diehl J et al. Divergent hemodynamic and hormonal responses to varying salt intake in normotensive subjects. Hypertension 1993; 22: 331-338.
43. Skrabal F, Aubock J, Hortnagl H. Low sodium/high potassium diet for prevention of hypertension: Probable mechanisms of action. Lancet 1981; 2: 895-900.
44. Brown MD, Hogikyan RV, Dengel DR, Supiano MA. Sodium-sensitive hypertension is not associated with higher sympathetic nervous system activity in older hypertensive humans. Am J Hypertens 2000; 13 873-883.
45. Kong JQ, Taylor DA, Fleming WW. Antagonism of norepinephrine by clonidine in the isolated rat mesenteric vascular bed. J Pharmacol Exp Ther 1991; 259: 653-658.
46. Ekas Jr RD, Lokhandwala MF. Sympathetic nerve function and vascular reactivity in Doca-salt hypertensive rats. Am J Physiol 1980; 239: R303-R308.
47. Skrabal F, Kotanko P, Luft PC. Inverse regulation of alpha-2 and beta-2 adrenoceptors in salt-sensitive hypertension: An hypothesis. Life Sci 1989; 45: 2061-2076.
48. Sharma AM, Schorr U, Oelkers W, Distler A. Effects of sodium salts on plasma renin activity and norepinephrine response to orthostasis in salt-sensitive normotensive subjects. Am J Hypertens 1993; 6 9): 780-785.
49. Spieker LE, Hürlimann D, Ruschitzka F, Corti R, Enseleit F, Shaw S et al. Mental stress induces prolonged endothelial dysfunction via endothelin. A receptors. Circulation 2002; 105(24): 2817-2820.
50. al'Absi M, Lovallo WR, McKey BS, Pincomb GA. Borderline hypertensives produce exaggerated adreno-cortical responses to mental stress. Psychosom Med 1994; 56: 245-250.
51. al'Absi M, Arnett DK. Adrenocortical responses to psychological stress and risk for hypertension. Biomed Pharmacother 2000; 54: 234-244.
52. Watt GC, Harrap SB, Foy CJ, Holton DW, Edwards HV, Davidson HR et al Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: A four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992; 10: 473-482.
53. Yang S, Zhang L. Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol 2004; 2: 1-12.
54. Sudhir K, Jennings GL, Esler MD, Korner PI, Blombery PA, Lambert GW et al. Hydrocortisone-induced hypertension in humans: Pressor responsiveness and sympathetic function. Hypertension 1989; 13 416-421.
55. Burns VE, Ring C, Drayson M, Carroll D. Cortisol and cardiovascular reactions to mental stress and antibody status following hepatitis B vaccination: A preliminary study. Psychophysiology 2002; 39: 361-368.
56. Isowa T, Ohira H, Murashima S. Immune, endocrine and cardiovascular responses to controllable and uncontrollable acute stress. Biol Psychol 2006; 71: 202-213.
57. Larson MR, Ader R, Moynihan JA. Heart rate, neuroendocrine, and immunological reactivity in response to an acute laboratory stressor. Psychosom Med 2001; 63: 493-501.
58. DeQuattro V, Feng M. The sympathetic nervous system: The muse of primary hypertension. J Hum Hypertens 2002; 16: 864-S69.
59. Diario D, Viau V, Meaney MJ. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci 1993; 13: 3839-3847.
60. Thayer JF, Lane RD. The role of vagal function in the risk for cardiovascular disease and mortality. Biol Psychology 2007; 74 224-242.